An investor asked a question on the investor interaction platform: May I ask the Secretary: on March 10, Shanxi pharmaceutical machinery centralized bidding and procurement center announced that it would carry out the centralized procurement of a variety of traditional Chinese medicines in accordance with the requirements of the notice on filling in relevant data of some varieties of traditional Chinese medicines issued by Sanming Procurement Alliance (National) office. 1. What is the specific impact on Guizhou Bailing Group Pharmaceutical Co.Ltd(002424) performance of the centralized purchase of Chinese Herbal Pieces in the future. 2. Since 2015, Guizhou Bailing Group Pharmaceutical Co.Ltd(002424) has been engaged in large-scale cultivation of Radix Pseudostellariae. What is the current planting scale of Radix Pseudostellariae and whether there are benefits.
Guizhou Bailing Group Pharmaceutical Co.Ltd(002424) ( Guizhou Bailing Group Pharmaceutical Co.Ltd(002424) . SZ) said on the investor interaction platform on March 21 that at present, the traditional Chinese medicine planted by the company is mainly used for its own production needs, and the variety of Radix Pseudostellariae has not been planted in recent years.
